SCDM CCDM Exam With Confidence Using Practice Dumps

The best choice for managingStandard Operating Procedures (SOPs)in a compliant and auditable manner is aDocument Management System (DMS).

According to theGCDMP (Chapter: Regulatory Requirements and Compliance)andICH E6 (R2), SOPs must beversion-controlled, securely stored, retrievable, and auditable. Avalidated DMSsupports controlled access, document lifecycle management (draft, review, approval, and archival), and electronic audit trails, ensuring full compliance withFDA 21 CFR Part 11andGood Documentation Practices (GDP).

WhileLearning Management Systems (C)track training, they are not intended for document control.Spreadsheets (B)andpaper systems (D)cannot provide adequate version tracking, access security, or audit capability required for regulatory inspection readiness.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Regulatory Requirements and Compliance, Section 5.2 – SOP Management and Document Control

ICH E6 (R2) GCP, Section 5.5.3 – Document and Record Management

FDA 21 CFR Part 11 – Electronic Records and Signatures, Section 11.10 – System Validation and Document Controls

Assuming the data transfer, integration, and validation processes are properly controlled and compliant,electronic acquisitionof clinical data from medical devices is preferred because it allowsmore frequent and accurate data collection, leading to higher data resolution and integrity.

Per theGCDMP (Chapter: Technology and Data Integration), automated data collection minimizes manual transcription and reduces latency in data capture, ensuring both efficiency and completeness. While manual processes introduce human transcription errors and limit frequency, continuous electronic data capture can record thousands of accurate, time-stamped measurements, improving the study’s analytical power.

However,option Dslightly overstates the case — human error isreduced, not entirely eliminated, since setup, calibration, and integration still involve human oversight. Therefore,option Cis the best and most precise response, emphasizing the advantage of more robust and complete data capture.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Technology and Data Integration, Section 5.4 – Automated Data Acquisition and Validation

ICH E6(R2) GCP, Section 5.5.3 – Validation of Computerized Systems and Electronic Data Sources

FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.3 – Direct Data Capture from Instruments and Devices

When coding adverse events (AEs) usingMedDRA (Medical Dictionary for Regulatory Activities), valid AE terms must correspond to specific, medically meaningful concepts thatmatch directly to a Preferred Term (PT)orLowest Level Term (LLT)in the dictionary.

Among the options,“Elevated HDL”(High-Density Lipoprotein) represents a single, medically interpretable, and standard term that can directly match to a MedDRA LLT or PT. This makes it suitable forauto-coding, where the system automatically maps verbatim terms to MedDRA entries without manual intervention.

In contrast:

ALT (B)andAbnormal SGOT (C)are incomplete or nonspecific; they describe test names or qualitative interpretations rather than events.

Option Dlists multiple findings, making it too complex for automatic mapping. Such compound entries would requiremanual coding review.

According toGCDMP (Chapter: Medical Coding and Dictionaries), a valid AE term should be:

Clinically interpretable(not just a lab test name)

Unambiguous

Single-concept based, not a collection of results

Thus,option A (Elevated HDL)is correct, as it aligns with MedDRA’s single-concept, standard terminology structure suitable for auto-coding.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Medical Coding and Dictionaries, Section 5.3 – Auto-coding and Verbatim Term Management

ICH M1 MedDRA Term Selection: Points to Consider, Section 2.1 – Coding Principles

ICH E2B(R3) – Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports